TP53 and cancer: As a benchmarking system,we selected the oncoprotein MDM2, a well-characterizedregulator of the tumor suppressor p53 and a key player in cancer biology. MDM2 binds to the N-terminal transactivationdomain of p53, a short α-helical motif, thereby inhibiting itstumor-suppressive function.